New blood cancer therapy approved in the U.S.
The therapy’s approval comes with FDA’s “boxed” safety warning, flagging the risk of a type of aggressive immune response and neurologic toxicity.
Source: q107.com
Page 2 - Michael Andreini News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Andreini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Andreini Today - Breaking & Trending Today
FDA OKs Talquetamab, a First-in-Class Multiple Myeloma Drug
The approval follows a series of market withdrawals for other multiple myeloma drugs that initially received accelerated FDA approval.
Source: medscape.com
Moving Mountains for Multiple Myeloma® Program to Trek Through Alaska, July 23-29
A group of 11 hikers will embark on this incredible challenge to raise awareness and funds for multiple myeloma research through the Multiple Myeloma Research Foundation (MMRF) As part of the Moving Mountains for
Source: benzinga.com
FDA OKs Teclistamab for Relapsed/Refractory Multiple Myeloma
Teclistamab is now an option after progression on triple-class therapy; however, the FDA also issued a Boxed Warning for life-threatening or fatal cytokine release syndrome and neurologic toxicity.
Source: medscape.com
Moving Mountains for Multiple Myeloma® Tackles Mt.
Mt. Washington MM4MM hikers take on the challenging climb in July to increase awareness and fundraise for multiple myeloma research...
Source: globenewswire.com